ConductScience.org, home

Gene · 10481

HOXB13: homeobox B13

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. HOXB13: homeobox B13. Genes, record 10481. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/10481

On this page

Gene

Symbol
HOXB13
HGNC
Name
homeobox B13
HGNC
NCBI Gene ID
10481
NCBI Gene
HGNC ID
HGNC:5112
HGNC
Ensembl
ENSG00000159184
NCBI Gene
Aliases
HPC9, PSGD
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q92826Homeobox protein Hox-B1328410Ensembl, GeneID, HGNC

Source UniProt

Patents63

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
EP 4805378 A12026-09-16111Q92826Espacenet
JP 2026523341 A2026-07-14570Q92826Espacenet
EP 4771137 A12026-07-08108Q92826Espacenet
EP 4771157 A12026-07-08108Q92826Espacenet
US 12649003 B22026-06-09570Q92826Espacenet
JP 2026510339 A2026-04-02108Q92826Espacenet
EP 4713451 A22026-03-25108Q92826Espacenet
EP 4713452 A22026-03-25108Q92826Espacenet
US 12558437 B22026-02-24570Q92826Espacenet
EP 4677082 A22026-01-14108Q92826Espacenet

1 to 10 of 63

See all 63 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants1,266

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleHOXB13 papersNewest fiscal year
P30CA008748Cancer Center Support Grant352025
P50CA097186The Pacific Northwest Prostate Cancer SPORE292025
P01CA163227Androgen Receptor Action in Castration Resistant Prostate Cancer222025
P30CA006973Regional Oncology Research Center202025
P30CA016672Cancer Center Support Grant182025
P50CA186786Michigan Prostate SPORE 2025-2030182025
P50CA092629SPORE in Prostate Cancer172025
P50CA180995SPORE in Prostate Cancer132025
P30CA015704Cancer Center Support Grant102025
P30CA016042Cancer Center Support Grant82025

1 to 10 of 1,266Source NIH's project files

See all 1,266 nih grants

Papers1,917

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Breast Cancer Index and Recommendations for Extended Endocrine Therapy.JAMA Netw Open202642783373PubTator, text miningPubMed
Post-translational modifications in prostate cancer: coordinated oncogenic networks and clinical implications.Biochim Biophys Acta Rev Cancer202642637058PubTator, text miningPubMed
Correction to "Homeobox B13 activates the hypoxia-inducible factor 1 pathway through histone lactylation thereby reprogramming lipid metabolism and promoting sorafenib resistance in hepatocellular carcinoma".
J Cell Commun Signal202642621181PubTator, text miningPubMed
Germline HOXB13 G84E Variant in a Patient with Gastric and Prostate Cancer: A Case Report and Literature Review.Case Rep Oncol202642578161PubTator, text miningPubMed
Unified genetic risk score for prostate cancer enables improved risk stratification for clinical decision-making.J Med Genet202642527158PubTator, text miningPubMed
Revisiting familial aggregation of prostate cancer within the 3D framework of genetics-epigenetics-environment.Mutat Res Rev Mutat Res202642492399PubTator, text miningPubMed
Miniaturized HOXB13 Mimetics Are Sequence-Specific, Methyl-Sensitive DNA Binders.J Am Chem Soc202642445955PubTator, text miningPubMed
HOXB13 Is a Sensitive and Specific Diagnostic Marker for Myxopapillary Ependymoma.Am J Surg Pathol202642444158PubTator, text miningPubMed
Hereditary Cancer Genetic Testing for All? A Retrospective Analysis on Genetic Mutations Found in Individuals Not Meeting NCCN® Guidelines.Eur J Breast Health202642317085PubTator, text miningPubMed
The 'Prostate Cancer Screening for People at Genetic Risk of Aggressive Disease' (PATROL) study.BJU Int202642265755PubTator, text miningPubMed

1 to 10 of 1,917

See all 1,917 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/10481

GET https://conductscience.org/api/genes/v1/10481/patents?page=2